CXCL9 and tuberculosis: It has been indicated that IP-10 secretion can also be used as a biomarker for tuberculosis (Qiu et al., 2019) and both IP-10 and MIG cytokines are both known to be upregulated in response to infection with Mycobacterium tuberculosis (Yang et al., 2014).